Published in Am J Epidemiol on February 15, 2003
Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol (2003) 2.45
Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sex Transm Infect (2005) 1.28
Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research. Sex Transm Dis (2009) 1.16
Translation of biomedical prevention strategies for HIV: prospects and pitfalls. J Acquir Immune Defic Syndr (2013) 1.12
Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards. Contraception (2012) 0.92
Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance. Contraception (2012) 0.87
Vaginal swab specimen processing methods influence performance of rapid semen detection tests: a cautionary tale. Contraception (2010) 0.86
Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studies. Contraception (2012) 0.85
Objective non-intrusive markers of sperm production and sexual activity. Asian J Androl (2012) 0.81
Do women using long-acting reversible contraception reduce condom use? A novel study design incorporating semen biomarkers. Infect Dis Obstet Gynecol (2011) 0.78
A quantitative glycogen assay to verify use of self-administered vaginal swabs. Sex Transm Dis (2012) 0.78
Prostate-specific antigen is unlikely to be a suitable biomarker of semen exposure from recent unprotected receptive anal intercourse in men who have sex with men. Sex Transm Dis (2014) 0.77
The use of biomarkers of semen exposure in sexual and reproductive health studies. J Womens Health (Larchmt) (2014) 0.77
Reducing HIV/AIDS transmission among African-American females: is the female condom a solution? J Natl Med Assoc (2005) 0.75
Assessment of the vaginal residence time of biomarkers of semen exposure. Contraception (2016) 0.75
Building young women's knowledge and skills in female condom use: lessons learned from a South African intervention. Health Educ Res (2016) 0.75
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet (2008) 19.65
New intrauterine growth curves based on United States data. Pediatrics (2010) 3.72
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med (2011) 2.71
Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. J Acquir Immune Defic Syndr (2002) 2.48
Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials (2008) 2.35
A patient-controlled journal for an electronic medical record: issues and challenges. Stud Health Technol Inform (2004) 2.35
Partner characteristics, intensity of the intercourse, and semen exposure during use of the female condom. Am J Epidemiol (2003) 1.92
The acceptability of the female and male condom: a randomized crossover trial. Perspect Sex Reprod Health (2004) 1.90
Experience and modification update for the minimally invasive Nuss technique for pectus excavatum repair in 303 patients. J Pediatr Surg (2002) 1.82
Local anesthetic and stylet styles: factors associated with resident lumbar puncture success. Pediatrics (2006) 1.79
Maternal mortality among Afghan refugees in Pakistan, 1999-2000. Lancet (2002) 1.74
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest (2011) 1.73
The use of nonhuman primate models in HIV vaccine development. PLoS Med (2008) 1.73
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. Curr Opin HIV AIDS (2010) 1.63
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
Performance evaluation of blood glucose monitoring devices. Diabetes Technol Ther (2003) 1.56
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol (2009) 1.56
Use of a body proportionality index for growth assessment of preterm infants. J Pediatr (2008) 1.54
Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol (2013) 1.45
Seroprevalence of human herpesvirus 8 infection in Northern Thailand. Clin Infect Dis (2004) 1.45
Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi. Contemp Clin Trials (2006) 1.45
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis (2007) 1.37
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
Randomized controlled trial of health maintenance reminders provided directly to patients through an electronic PHR. J Gen Intern Med (2011) 1.27
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads. J Acquir Immune Defic Syndr (2008) 1.26
Breast milk and HIV-1: vector of transmission or vehicle of protection? Lancet Infect Dis (2003) 1.20
Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol (2007) 1.20
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol (2006) 1.20
Survival of blood donors and their spouses with HIV-1 subtype E (CRF01 A_E) infection in northern Thailand, 1992-2007. AIDS (2007) 1.19
Surgical repair of pectus excavatum markedly improves body image and perceived ability for physical activity: multicenter study. Pediatrics (2008) 1.19
Self-reported mechanical problems during condom use and semen exposure. Comparison of two randomized trials in the United States of America and Brazil. Sex Transm Dis (2007) 1.13
Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol (2002) 1.12
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity. PLoS One (2010) 1.09
Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi. AIDS Educ Prev (2009) 1.07
Prospective multicenter study of surgical correction of pectus excavatum: design, perioperative complications, pain, and baseline pulmonary function facilitated by internet-based data collection. J Am Coll Surg (2007) 1.07
Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol (2006) 1.06
Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J Acquir Immune Defic Syndr (2005) 1.06
Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner. J Infect Dis (2003) 1.05
Multicenter study of pectus excavatum, final report: complications, static/exercise pulmonary function, and anatomic outcomes. J Am Coll Surg (2013) 1.03
Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles. PLoS Pathog (2011) 1.00
Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine (2004) 1.00
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination. J Clin Invest (2002) 0.99
A critical appraisal of evidence supporting a bariatric surgical approach to weight management for adolescents. J Pediatr (2005) 0.98
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Clin Infect Dis (2002) 0.97
T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr (2007) 0.97
Large refractive index change in silicone-based and non-silicone-based hydrogel polymers induced by femtosecond laser micro-machining. Opt Express (2006) 0.97
Surfer's ear: external auditory exostoses are more prevalent in cold water surfers. Otolaryngol Head Neck Surg (2002) 0.97
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study. AIDS (2011) 0.94
Pectus excavatum in a 112-year autopsy series: anatomic findings and the effect on survival. J Pediatr Surg (2005) 0.93
The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis (2002) 0.93
Reasons for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection. Pediatrics (2006) 0.93
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. AIDS Res Hum Retroviruses (2010) 0.93
Empowering patients to improve the quality of their care: design and implementation of a shared health maintenance module in a US integrated healthcare delivery network. Stud Health Technol Inform (2007) 0.92
Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr (2006) 0.92
Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis (2006) 0.92
Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection. Infect Dis Obstet Gynecol (2005) 0.92
Acceptability of five nonoxynol-9 spermicides. Contraception (2005) 0.91
Reproductive options for HIV-serodiscordant couples. AIDS Rev (2006) 0.90
Comparing Measures of Late HIV Diagnosis in Washington State. AIDS Res Treat (2011) 0.89
Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy. J Infect Dis (2007) 0.89
Safe conception for HIV discordant couples through sperm-washing: experience and perceptions of patients in Milan, Italy. Reprod Health Matters (2008) 0.88
Predictors of low CD4 count in resource-limited settings: based on an antiretroviral-naive heterosexual thai population. J Acquir Immune Defic Syndr (2005) 0.87
Effectiveness of health maintenance reminders provided directly to patients. AMIA Annu Symp Proc (2008) 0.86
Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection. Am J Clin Nutr (2007) 0.85
Stability of adolescent body mass index during three years of follow-up. J Pediatr (2007) 0.85
Implications of blood contamination for assessment of local cellular immunity in the endocervix. AIDS Res Hum Retroviruses (2004) 0.84
Effect of spontaneous pregnancy reduction on obstetric outcome. J Reprod Med (2005) 0.83
Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives. AIDS Res Hum Retroviruses (2002) 0.82
Validation of a weight history questionnaire to identify adolescent obesity. Obes Surg (2013) 0.82
Reliability of a staging assessment system for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol (2003) 0.82
The potential role of biomarkers in HIV preventive vaccine trials. J Acquir Immune Defic Syndr (2009) 0.81
Frequencies of IL10 SNP genotypes by multiplex PCR-SSP and their association with viral load and CD4 counts in HIV-1-infected Thais. Asian Pac J Allergy Immunol (2011) 0.80
High prevalence of self-reported forced sexual intercourse among internally displaced women in Azerbaijan. Am J Public Health (2003) 0.80
Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics. J Control Release (2004) 0.79
Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration. Fertil Steril (2003) 0.79
Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop. J Acquir Immune Defic Syndr (2007) 0.79
Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomy. J Acquir Immune Defic Syndr (2004) 0.79
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition. AIDS (2016) 0.78
Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Med Res Methodol (2004) 0.78
Do women with HIV infection have different indications for hysterectomy? J Acquir Immune Defic Syndr (2005) 0.78
HIV-discordant couples and parenthood: how are we dealing with the risk of transmission? AIDS (2006) 0.77
Fertility outcomes after electroejaculation in men with spinal cord injury. Fertil Steril (2002) 0.77
Reply to Richie and Villasante. J Infect Dis (2012) 0.77
Higher protein intake improves length, not weight, z scores in preterm infants. J Pediatr Gastroenterol Nutr (2014) 0.76
HIV vaccine efficacy trials: towards the future of HIV prevention. Infect Dis Clin North Am (2007) 0.76
Lymphocyte homeostasis in HIV-infected northern Thais. AIDS Res Hum Retroviruses (2004) 0.76
Overestimation of urinary peptide excretion. Am J Kidney Dis (2005) 0.75
Utilization, reliability, and clinical impact of point-of-care testing during critical care transport: six years of experience. Clin Chem (2003) 0.75
HIV treatment as prevention: [corrected] next steps. Curr Opin HIV AIDS (2012) 0.75
Prevention of perinatal HIV transmission: a review of novel strategies. Expert Opin Investig Drugs (2003) 0.75